News

A new piece of research has provided further evidence to suggest that individuals who take aspirin have a lower risk of developing breast cancer. Researchers collected information from 57,000 female teachers in California over a period of more than 15 years. ...

The Add-Aspirin trial office is now fully back up and running following the power outage over Easter, apologies for any inconvenience caused...

Please note the MRCCTU office and randomisation phoneline will be closed on Friday 14th and Monday 17th April and will reopen at 9am on Tuesday 18th April. Please make sure to randomise participants either before or after the Easter weekend...

Further research has provided more evidence to suggest that individuals who take aspirin have a lower risk of dying from cancer. Researchers looked at data from two very large studies that followed groups of nurses and other healthcare professionals (more than 130,000 people in total) over a period of up to 32 years...

The Add-Aspirin Trial is pleased to formally notify sites of the Substantial Amendment for Protocol version 5.0 and updated participant materials...